Jolife announces an extended distribution contract with Physio-Control and the availability of the LUCAS™ Chest Compression System in the US
October 9, 2007, Lund, Sweden
Jolife AB announces the extension of the distribution contract with Physio-Control Inc., which entails the rights to global distribution of the LUCAS Chest Compression System. The LUCAS Chest Compression System, which is developed and manufactured by Jolife, is currently being launched in the United States, the world’s largest market for medical devices. Physio-Control Inc., a wholly owned subsidiary of Medtronic Inc., is a world-leading manufacturer and distributor of defibrillators for the treatment of cardiac arrest.
Says Erik von Schenck, Chief Executive Officer of Jolife: “We are very pleased to continue to cooperate with Physio-Control, and with the current launch in the US. LUCAS complements Physio-Control’s product portfolio perfectly. We are excited to continue the global expansion of the LUCAS Chest Compression System and specifically to have access to a strong and knowledgeable sales force for the launch in the US.”
The new contract gives Physio-Control the exclusive global distribution rights to LUCAS, with the exception of the Swedish, Norwegian and Finnish markets. Jolife has decided to take back sales responsibility in these markets to ensure closer contact with end-customers.
For Physio-Control’s press release – read more in Medtronic’s Newsroom on their website www.medtronic.com or click the link (http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1191848926409&lang=en_US)
About LUCAS™ CPR
The LUCAS™ Chest Compression System assists ambulance and hospital professionals in saving cardiac arrest victims by providing continuous compressions, which helps sustain blood flow to the brain and heart. The AHA/ERC guidelines from 2005 emphasize uninterrupted chest compressions before defibrillation. LUCAS provides chest compressions without rescuer fatigue or variations in quality. The device enables safe transportation and allows for simultaneous defibrillation and angioplasty.
About Jolife AB
Jolife is dedicated to increasing the survival rates related to sudden cardiac arrest and the quality of life of the survivors by developing innovative devices for resuscitation. Founded in 2000, the company works closely with leading physicians and paramedics in research and development. The work has led to groundbreaking knowledge about the physiological effects of a cardiac arrest and the significance of quality compressions. The LUCAS Chest Compression System is available for sale in the US, Europe and several other geographies. Jolife is based in Sweden, and markets its products through an exclusive distributor agreement. For more information, please visit www.jolife.com and www.lucas-cpr.com or contact: Erik von Schenck, CEO, Jolife AB +46 733 14 74 71